Collegium Pharmaceutical
COLL
COLL
221 hedge funds and large institutions have $1.05B invested in Collegium Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 88 increasing their positions, 83 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
221
Holders Change
-20
Holders Change %
-8.3%
% of All Funds
2.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
88
Reduced
83
Closed
34
Calls
$372K
Puts
$17K
Net Calls
+$355K
Net Calls Change
-$78K
Top Buyers
| 1 |
JGC
J. Goldman & Co
New York
|
+$7.2M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.66M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$4.43M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$4.04M |
| 5 |
BAM
Ballast Asset Management
Dallas,
Texas
|
+$2.58M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$12.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7.98M |
| 3 |
QC
Quantedge Capital
Singapore
|
-$7.1M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$5.87M |
| 5 |
BlackRock
New York
|
-$3.32M |
